These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32074225)

  • 41. A malignant hyperthermia-like reaction in a six-month-old female with a 5q chromosomal deletion.
    Greenberg M; Faierman A; Fisher B; Harris B
    Can J Anaesth; 2005; 52(7):772-3. PubMed ID: 16103395
    [No Abstract]   [Full Text] [Related]  

  • 42. Malignant hyperthermia developing during esophageal resection in an 82-year-old man.
    Nakamura N; Ueda T; Ishikawa R; Tasaka Y; Fukuuchi K; Sato N
    J Anesth; 2008; 22(4):464-6. PubMed ID: 19011791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malignant hyperthermia in the absence of triggering agents.
    Setzer-Saade N
    Anesth Analg; 2010 Sep; 111(3):822; author reply 822-3. PubMed ID: 20733170
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful management of malignant hyperthermia during orthognathic surgery: a case report.
    Laureano Filho JR; de Oliveira Neto PJ; Duarte N; Caetana A; Chagas Ada S
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1485-8. PubMed ID: 18571035
    [No Abstract]   [Full Text] [Related]  

  • 45. Delayed onset of malignant hyperthermia in desflurane anesthesia.
    Hoenemann CW; Halene-Holtgraeve TB; Booke M; Hinder F; Daudel F; Reich A; Van Aken H
    Anesth Analg; 2003 Jan; 96(1):165-7, table of contents. PubMed ID: 12505945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delayed onset of malignant hyperthermia in the intensive care unit: a rare but life-threatening disorder.
    Twine N
    Crit Care Nurs Q; 2013; 36(2):213-7. PubMed ID: 23470706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
    Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N
    Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis.
    Green G
    Acta Anaesthesiol Scand; 2003 May; 47(5):619-21. PubMed ID: 12699524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
    Brandom BW; Larach MG; Chen MS; Young MC
    Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil].
    Almeida da Silva HC; Ferreira G; Rodrigues G; Santos JMD; Andrade PV; Hortense A; Vaz Perez M; Amaral JLGD
    Braz J Anesthesiol; 2019; 69(2):152-159. PubMed ID: 30935497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delayed onset of sevoflurane-induced juvenile malignant hyperthermia after second exposure.
    Chen PL; Day YJ; Su BC; Lee PC; Chen CY
    Acta Anaesthesiol Taiwan; 2007 Sep; 45(3):189-93. PubMed ID: 17972624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minor increase of endtidal CO2 during sevoflurane-induced malignant hyperthermia.
    Bonciu M; de la Chapelle A; Delpech H; Depret T; Krivosic-Horber R; Aimé MR
    Paediatr Anaesth; 2007 Feb; 17(2):180-2. PubMed ID: 17238892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Malignant hyperthermia].
    Chastonay P; Bracco D; Freymond D; Ravussin P
    Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Case of fulminant-malignant hyperthermia occurring on sixth sevoflurane anesthesia].
    Sugiyama K; Toya A; Shimomatsu K; Saitoh Y; Manabe Y; Kohjitani A
    Masui; 2011 Jun; 60(6):703-5. PubMed ID: 21710767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of epileptiform discharges in children during induction of anaesthesia using Propofol versus Sevoflurane.
    Koch S; Rupp L; Prager C; Mörgeli R; Kramer S; Wernecke KD; Fahlenkamp A; Spies C
    Clin Neurophysiol; 2018 Aug; 129(8):1642-1648. PubMed ID: 29913339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of malignant hyperthermia without hyperthermia].
    Muiños PA; Ortells MA; Sánchez G; Carrasco MS
    Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530
    [No Abstract]   [Full Text] [Related]  

  • 57. Recognizing and treating malignant hyperthermia.
    Corvetto MA; Taekman JM
    Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479
    [No Abstract]   [Full Text] [Related]  

  • 58. [Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery].
    Itoh K; Nishibe S; Usuda Y; Kitamura A
    Masui; 2014 Oct; 63(10):1153-5. PubMed ID: 25693350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed onset of suspected malignant hyperthermia during sevoflurane anesthesia in an Afghan trauma patient: a case report.
    Banek R; Weatherwax J; Spence D; Perry S; Muldoon S; Capacchione J
    AANA J; 2013 Dec; 81(6):441-5. PubMed ID: 24597005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy.
    Nakano M; Funayama M; Takata T; Wakisaka R; Koyama G; Koreki A; Ishida T; Uchida H; Mimura M
    BMC Psychiatry; 2024 Jun; 24(1):411. PubMed ID: 38834964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.